1. DickinsonPJ, LeCouteur RA. Muscle and nerve biopsy. Vet Clin North Am Small Anim Pract. 2002:32:63-102.
2. Dubowitz V, Sewry CA, Oldfors A. Histological and histochemical changes. In: Muscle Biopsy: A Practical Approach. 4th ed. Elsevier, 2013:55-94.
3. Barohn RJ, Dimachkie MM, Jackson CE. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin. 2014 Aug;32(3):569-93.
4. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008 Mar;119(3):497-503.
5. Daube JR, Rubin DI. Needle electromyography. Muscle Nerve. 2009 Feb;39(2):244-70.
6. Daube JR, Rubin DI. Clinical neurophysiology. 4th ed. Oxford University Press, 2016.
7. Preston C, Shapiro E. Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations. 3th ed. Elsevier, 2013.
8. Schoser B. Diagnostic muscle biopsy: is it still needed on the way to a liquid muscle pathology? Curr Opin Neurol. 2016 Oct;29(5):602-5.
9. North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, Amburgey K, Quijano-Roy S, Beggs AH, Sewry C, Laing NG, Bönnemann CG; International Standard of Care Committee for Congenital Myopathies. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014 Feb;24(2):97-116.
10. Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43(3-4):259-68.
11. Lalic T, Vossen RH, Coffa J, Schouten JP, Guc-Scekic M, Radivojevic D, Djurisic M, Breuning MH, White SJ, den Dunnen JT. Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet. 2005 Nov;13(11):1231-4.
12. Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet PY, Joncourt F, Díaz-Manera J, Gallardo E, Karaduman AA, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Béroud C, Lochmüller H. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015 Apr;36(4):395-402.
13. Nakamura H, Kimura E, Mori-Yoshimura M, Komaki H, Matsuda Y, Goto K, Hayashi YK, Nishino I, Takeda S, Kawai M. Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy). Orphanet J Rare Dis. 2013 Apr 19;8:60.
14. Takeuchi F, Yonemoto N, Nakamura H, Shimizu R, Komaki H, Mori-Yoshimura M, Hayashi YK, Nishino I, Kawai M, Kimura E, Takeda S. Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients. J Neurol. 2013 Dec;260(12):3023-9.
15. Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, Roy A, Chamova T, Guergueltcheva V, Korngut L, Campbell C, Dai Y, Barišić N, Kos T, Brabec P, Rahbek J, Lahdetie J, Tuffery-Giraud S, Claustres M, Leturcq F, Ben Yaou R, Walter MC, Schreiber O, Karcagi V, Herczegfalvi A, Viswanathan V, Bayat F, de la Caridad Guerrero Sarmiento I, Ambrosini A, Ceradini F, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Oliveira J, Santos R, Neagu E, Butoianu N, Artemieva S, Rasic VM, Posada M, Palau F, Lindvall B, Bloetzer C, Karaduman A, Topaloğlu H, Inal S, Oflazer P, Stringer A, Shatillo AV, Martin AS, Peay H, Flanigan KM, Salgado D, von Rekowski B, Lynn S, Heslop E, Gainotti S, Taruscio D, Kirschner J, Verschuuren J, Bushby K, Béroud C, Lochmüller H. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat. 2013 Nov;34(11):1449-57.
16. Manning J, O'Malley D. What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? J Muscle Res Cell Motil. 2015 Apr;36(2):155-67.
17. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989 Jun 30;244(4912):1578-80.
18. Nakamura K, Fujii W, Tsuboi M, Tanihata J, Teramoto N, Takeuchi S, Naito K, Yamanouchi K, Nishihara M. Generation of muscular dystrophy model rats with a CRISPR/Cas system. Sci Rep. 2014 Jul 9;4:5635.
19. Brinkmeyer-Langford C, Kornegay JN. Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model. Curr Genomics. 2013 Aug;14(5):330-42.
20. Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, Dasbach JJ, Rae JF, Moore FM, McAfee MB, et al. Feline muscular dystrophy with dystrophin deficiency. Am J Pathol. 1989 Nov;135(5):909-19.
21. Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH 3rd, Pearce LK. Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci. 1992 Jul;110(1-2):149-59.
22. Selsby JT, Ross JW, Nonneman D, Hollinger K. Porcine models of muscular dystrophy. ILAR J. 2015;56(1):116-26.
23. Kornegay JN. The golden retriever model of Duchenne muscular dystrophy. Skelet Muscle. 2017 May 19;7(1):9.
24. Vieira NM, Guo LT, Estrela E, Kunkel LM, Zatz M, Shelton GD. Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype. Neuromuscul Disord. 2015 May;25(5):363-70.
25. Zucconi E, Valadares MC, Vieira NM, Bueno CR Jr, Secco M, Jazedje T, da Silva HC, Vainzof M, Zatz M. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog. Neuromuscul Disord. 2010 Jan;20(1):64-70.
26. Shelton GD. Routine and specialized laboratory testing for the diagnosis of neuromuscular diseases in dogs and cats. Vet Clin Pathol. 2010 Sep;39(3):278-95.
27. Braund KG, Amling KA, Mehta JR, Steiss JE, Scholz C. Histochemical and morphometric study of fiber types in ten skeletal muscles of healthy young adult cats. Am J Vet Res. 1995 Mar;56(3):349-57.
28. Braund KG, Hoff EJ, Richardson EY. Histochemical identification of fiber types in canine skeletal muscle. Am J Vet Res. 1978 Apr;39(4):561-5.
29. Connolly AM, Pestronk A, Planer GJ, Yue J, Mehta S, Choksi R. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining. Neurology. 1996 Mar;46(3):810-14.
30. Engel WK. The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. 1962. Neurology. 1998 Sep;51(3):655-671.
31. Schmidt A. The significance of the detection of alkaline phosphatase in the diagnosis of neuromuscular diseases. Biomed Biochim Acta. 1986;45(1-2):S115-7.
32. Acevedo LM, Rivero JL. New insights into skeletal muscle fibre types in the dog with particular focus towards hybrid myosin phenotypes. Cell Tissue Res. 2006 Feb;323(2):283-303.
33. Strbenc M, Smerdu V, Zupanc M, Tozon N, Fazarinc G. Pattern of myosin heavy chain isoforms in different fibre types of canine trunk and limb skeletal muscles. Cells Tissues Organs. 2004;176(4):178-86.
34. Behan WM, Cossar DW, Madden HA, McKay IC. Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle. J Clin Pathol. 2002 May;55(5):375-80.
35. Raheem O, Huovinen S, Suominen T, Haapasalo H, Udd B. Novel myosin heavy chain immunohistochemical double staining developed for the routine diagnostic separation of I, IIA and IIX fibers. Acta Neuropathol. 2010 Apr;119(4):495-500.
36. Bennett GS, Fellini SA, Toyama Y, Holtzer H. Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro. J Cell Biol. 1979 Aug;82(2):577-84.
37. Carlsson L, Li Z, Paulin D, Thornell LE. Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knock-out mice. Exp Cell Res. 1999 Aug 25;251(1):213-23.
38. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 1993 Aug 5;364(6437):501-6.
39. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 1993 Aug 5;364(6437):532-5.
40. Osborn M, Geisler N, Shaw G, Sharp G, Weber K. Intermediate filaments. Cold Spring Harb Symp Quant Biol. 1982;46 Pt 1:413-29.
41. Sejersen T, Lendahl U. Transient expression of the intermediate filament nestin during skeletal muscle development. J Cell Sci. 1993 Dec;106 (Pt4):1291-300.
42. Vaittinen S, Lukka R, Sahlgren C, Rantanen J, Hurme T, Lendahl U, Eriksson JE, Kalimo H. Specific and innervation-regulated expression of the intermediate filament protein nestin at neuromuscular and myotendinous junctions in skeletal muscle. Am J Pathol. 1999 Feb;154(2):591-600.
43. Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev. 1997 Oct;7(5):597-602.
44. Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 1999 Jan 15;13(2):213-24.
45. Sjöberg G, Edström L, Lendahl U, Sejersen T. Myofibers from Duchenne/Becker muscular dystrophy and myositis express the intermediate filament nestin. J Neuropathol Exp Neurol. 1994 Jul;53(4):416-23.
46. Vaittinen S, Lukka R, Sahlgren C, Hurme T, Rantanen J, Lendahl U, Eriksson JE, Kalimo H. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol. 2001 Jun;60(6):588-97.
47. Wanschitz JV, Dubourg O, Lacene E, Fischer MB, Höftberger R, Budka H, Romero NB, Eymard B, Herson S, Butler-Browne GS, Voit T, Benveniste O. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis. Neuromuscul Disord. 2013 Jan;23(1):75-83.
48. Braund KG, Shores A, Lowrie CT, Steinberg HS, Moore MP, Bagley RS, Steiss JE. Idiopathic polyneuropathy in Alaskan malamutes. J Vet Intern Med. 1997 Jul-Aug;11(4):243-9.
49. Rentmeister K, Bilzer T, Petri S, Schanen G, Fehr M, Distl O, Tipold A. Hereditary polyneuropathy in the Alaskan Malamute. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2012;40(1):26-34.
50. Bruun CS, Jäderlund KH, Berendt M, Jensen KB, Spodsberg EH, Gredal H, Shelton GD, Mickelson JR, Minor KM, Lohi H, Bjerkås I, Stigen O, Espenes A, Rohdin C, Edlund R, Ohlsson J, Cizinauskas S, Leifsson PS, Drögemüller C, Moe L, Cirera S, Fredholm M. A Gly98Val mutation in the N-Myc downstream regulated gene 1 (NDRG1) in Alaskan Malamutes with polyneuropathy. PLoS One. 2013;8(2):e54547.
51. Vanhaesebrouck AE, Couturier J, Cauzinille L, Mizisin AP, Shelton GD, Granger N. Demyelinating polyneuropathy with focally folded myelin sheaths in a family of Miniature Schnauzer dogs. J Neurol Sci. 2008 Dec 15;275(1-2):100-105.
52. Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, Yuasa K, Tomohiro M, Kornegay JN, Nonaka I, Takeda S. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim. 2003 Apr;52(2):93-7.
53. Valentine BA, Cooper BJ, de Lahunta A, O'Quinn R, Blue JT. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci. 1988 Dec;88(1-3):69-81.
54. Valentine BA, Winand NJ, Pradhan D, Moise NS, de Lahunta A, Kornegay JN, Cooper BJ. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am J Med Genet. 1992 Feb 1;42(3):352-6.
55. Merlie JP, Mudd J, Cheng TC, Olson EN. Myogenin and acetylcholine receptor alpha gene promoters mediate transcriptional regulation in response to motor innervation. J Biol Chem. 1994 Jan 28;269(4):2461-7.
56. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell. 2010 Oct 1;143(1):35-45.
57. Tang H, Macpherson P, Marvin M, Meadows E, Klein WH, Yang XJ, Goldman D. A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol Biol Cell. 2009 Feb;20(4):1120-31.
58. Cuddon PA. Electrophysiology in neuromuscular disease. Vet Clin North Am Small Anim Pract. 2002 Jan;32(1):31-62.
59. Aleman M. Miscellaneous neurologic or neuromuscular disorders in horses. Vet Clin North Am Equine Pract. 2011 Dec;27(3):481-506.
60. Daube JR, Rubin DI. Needle electromyography. Muscle Nerve. 2009 Feb;39(2):244-70.
61. Fuglsang-Frederiksen A. The role of different EMG methods in evaluating myopathy. Clin Neurophysiol. 2006 Jun;117(6):1173-89.
62. Liguori R, Fuglsang-Frederiksen A, Nix W, Fawcett PR, Andersen K. Electromyography in myopathy. Neurophysiol Clin. 1997 Jun;27(3):200-3.
63. Braund KG. Diagnostic Techniques. In: Clinical syndromes in Veterinary Neurology. 2th ed. Mosby, 1994:332-52.
64. Farnbach GC. Clinical electrophysiology in veterinary neurology. Part I: Electromyography. Compend Contin Educ Pract Vet 1980;2:791–7.
65. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 3th ed. FA Davis, 1981:624.
66. Daube JR. Basic neurophysiology. In: Clinical Neurophysiology. 3th ed. Oxford University Press, 2009:69-95.
67. Buchthal F, Kamieniecka Z. The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders. Muscle Nerve. 1982 Apr;5(4):265-80.
68. Chang J, Park YG, Choi YC, Choi JH, Moon JH. Correlation of electromyogram and muscle biopsy in myopathy of young age. Arch Phys Med Rehabil. 2011 May;92(5):780-4.
69. Rabie M, Jossiphov J, Nevo Y. Electromyography (EMG) accuracy compared to muscle biopsy in childhood. J Child Neurol. 2007 Jul;22(7):803-8.
70. Dardiotis E, Papathanasiou E, Vonta I, Hadjigeorgiou G, Zamba-Papanicolaou E, Kyriakides T. A correlative study of quantitative EMG and biopsy findings in 31 patients with myopathies. Acta Myol. 2011 Jun;30(1):37-41.
71. Black JT, Bhatt GP, Dejesus PV, Schotland DL, Rowland LP. Diagnostic accuracy of clinical data, quantitative electromyography and histochemistry in neuromuscular disease. A study of 105 cases. J Neurol Sci. 1974 Jan;21(1):59-70.
72. Buchthal F. Electrophysiological signs of myopathy as related with muscle biopsy. Acta Neurol (Napoli). 1977 Jan-Feb;32(1):1-29.
73. Werneck LC, Lima JG. Muscle biopsy correlated with electromyography. Study of 100 cases. Arq Neuropsiquiatr. 1988 Jun;46(2):156-65.
74. Warmolts JR, Engel WK. Open-biopsy electromyography. I. Correlation of motor unit behavior with histochemical muscle fiber type in human limb muscle. Arch Neurol. 1972 Dec;27(6):512-7.
75. Naddaf E, Milone M, Mauermann ML, Mandrekar J, Litchy WJ. Muscle Biopsy and Electromyography Correlation. Front Neurol. 2018 Oct 9;9:839.
76. Sisson AF, LeCouteur RA, Ingram JT, Park RD, Child G. Diagnosis of cauda equina abnormalities by using electromyography, discography, and epidurography in dogs. J Vet Intern Med. 1992 Sep-Oct;6(5):253-63.
77. Oliver JE Jr, Selcer RR, Simpson S. Cauda equina compression from lumbosacral malarticulation and malformation in the dog. J Am Vet Med Assoc. 1978 Jul 15;173(2):207-14.
78. Giza EG, Płonek M, Nicpoń JM, Wrzosek MA. Electrodiagnostic studies in presumptive primary hypothyroidism and polyneuropathy in dogs with reevaluation during hormone replacement therapy. Acta Vet Scand. 2016 May 21;58(1):32.
79. de Carvalho M, Swash M. Fasciculation potentials and earliest changes in motor unit physiology in ALS. J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):963-8.
80. Griffiths IR, Duncan ID. Some studies of the clinical neurophysiology of denervation in the dog. Res Vet Sci. 1974 Nov;17(3):377-83.
81. Griffiths IR, Duncan ID. The use of electromyography and nerve conduction studies in the evaluation of lower motor neurone disease or injury. J Small Anim Pract. 1978 Jun;19(6):329-40.
82. Sener U, Martinez-Thompson J, Laughlin RS, Dimberg EL, Rubin DI. Needle electromyography and histopathologic correlation in myopathies. Muscle Nerve. 2019 Mar;59(3):315-320.
83. Bowen JM. Electromyography. Section 2. In: Veterinary Neurology. WB Saunders, 1987:145–68.
84. Kimura J. The F wave. In: Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. FA Davis, 1981:332–52.
85. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. FA Davis, 1981:624.
86. Shelton GD, Engvall E. Canine and feline models of human inherited muscle diseases. Neuromuscul Disord. 2005 Feb;15(2):127-38.
87. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, Scott MO, Fischbeck KH, Kornegay JN, Avery RJ, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature. 1988 Jul 14;334(6178):154-6.
88. Jones BR, Brennan S, Mooney CT, Callanan JJ, McAllister H, Guo LT, Martin PT, Engvall E, Shelton GD. Muscular dystrophy with truncated dystrophin in a family of Japanese Spitz dogs. J Neurol Sci. 2004 Feb 15;217(2):143-9.
89. Baroncelli AB, Abellonio F, Pagano TB, Esposito I, Peirone B, Papparella S, Paciello O. Muscular dystrophy in a dog resembling human becker muscular dystrophy. J Comp Pathol. 2014 May;150(4):429-33.
90. Dubowitz V, Sewry CA, Oldfors A. Facioscapulohumeral myotonic and oculopharyngeal muscular dystrophies. In: Muscle Biopsy: A Practical Approach. 4th ed. Elsevier, 2013:345-57.
91. Hahn C, Salajegheh MK. Myotonic disorders: A review article. Iran J Neurol. 2016 Jan 5;15(1):46-53.
92. Meola G, Cardani R. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta. 2015 Apr;1852(4):594-606.
93. Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol. 2007 Oct;20(5):572-6.
94. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005 Jul;32(1):1-18. Review.
95. Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord. 2005 Jan;15(1):5-16.
96. Duncan ID, Griffiths IR, McQueen A. A myopathy associated with myotonia in the dog. Acta Neuropathol. 1975;31(4):297-303.
97. Griffiths IR, Duncan ID. Myotonia in the dog: a report of four cases. Vet Rec. 1973 Aug 18;93(7):184-8.
98. Poncelet L, Fontaine J, Balligand M. Myotonia in two aged poodles. Vet Rec. 1991 Jun 22;128(25):599.
99. Simpson ST, Braund KG. Myotonic dystrophy-like disease in a dog. J Am Vet Med Assoc. 1985 Mar 1;186(5):495-8.
100. Smith BF, Braund KG, Steiss JE, Simpson ST, Cox NR, Sorjonen DC. Possible adult onset myotonic dystrophy in a boxer. J Vet Intern Med. 1998 Mar-Apr;12(2):120.
101. Kramer JW, Hegreberg GA, Bryan GM, Meyers K, Ott RL. A muscle disorder of Labrador retrievers characterized by deficiency of type II muscle fibers. J Am Vet Med Assoc. 1976 Oct 15;169(8):817-20.
102. McKerrell RE, Braund KG. Hereditary myopathy in Labrador retrievers: a morphologic study. Vet Pathol. 1986 Jul;23(4):411-7.
103. McKerrell RE, Braund KG. Hereditary myopathy in Labrador retrievers: clinical variations. J Small Anim Pract. 1987;28:479-89.
104. Gortel K, Houston DM, Kuiken T, Fries CL, Boisvert B. Inherited myopathy in a litter of Labrador retrievers. Can Vet J. 1996 Feb;37(2):108-10.
105. Watson AD, Farrow BR, Middleton DJ, Smyth JB. Myopathy in a Labrador retriever. Aust Vet J. 1988 Jul;65(7):226-7.
106. Pelé M, Tiret L, Kessler JL, Blot S, Panthier JJ. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet. 2005 Jun 1;14(11):1417-27.
107. Maurer M, Mary J, Guillaud L, Fender M, Pelé M, Bilzer T, Olby N, Penderis J, Shelton GD, Panthier JJ, Thibaud JL, Barthélémy I, Aubin-Houzelstein G, Blot S, Hitte C, Tiret L. Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide. PLoS One. 2012;7(10):e46408.
108. Bergman RL, Inzana KD, Monroe WE, Shell LG, Liu LA, Engvall E, Shelton GD. Dystrophin-deficient muscular dystrophy in a Labrador retriever. J Am Anim Hosp Assoc. 2002 May-Jun;38(3):255-61.
109. Denic V, Weissman JS. A molecular caliper mechanism for determining very long-chain fatty acid length. Cell. 2007 Aug 24;130(4):663-77.
110. Ikeda M, Kanao Y, Yamanaka M, Sakuraba H, Mizutani Y, Igarashi Y, Kihara A. Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett. 2008 Jul 9;582(16):2435-40.
111. Valentine BA, Winand NJ, Pradhan D, Moise NS, de Lahunta A, Kornegay JN, Cooper BJ. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am J Med Genet. 1992 Feb 1;42(3):352-6.
112. Puustjärvi K, Tammi M, Reinikainen M, Helminen HJ, Paljärvi L. Running training alters fiber type composition in spinal muscles. Eur Spine J. 1994;3(1):17-21.
113. O'Brien DP, Johnson GC, Liu LA, Guo LT, Engvall E, Powell HC, Shelton GD. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci. 2001 Aug 15;189(1-2):37-43.
114. Poncelet L, Résibois A, Engvall E, Shelton GD. Laminin alpha2 deficiency-associated muscular dystrophy in a Maine coon cat. J Small Anim Pract. 2003 Dec;44(12):550-2.
115. Uncini A, Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018 Dec;129(12):2586-93.
116. Añor S. Acute lower motor neuron tetraparesis. Vet Clin North Am Small Anim Pract. 2014 Nov;44(6):1201-22.
117. Cuddon PA. Electrophysiologic assessment of acute polyradiculoneuropathy in dogs: comparison with Guillain-Barré syndrome in people. J Vet Intern Med. 1998 Jul-Aug;12(4):294-303.
118. Hirschvogel K, Jurina K, Steinberg TA, Matiasek LA, Matiasek K, Beltrán E, Fischer A. Clinical course of acute canine polyradiculoneuritis following treatment with human IV immunoglobulin. J Am Anim Hosp Assoc. 2012 Sep-Oct;48(5):299-309.
119. Coates JR, March PA, Oglesbee M, Ruaux CG, Olby NJ, Berghaus RD, O'Brien DP, Keating JH, Johnson GS, Williams DA. Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs. J Vet Intern Med. 2007 Nov-Dec;21(6):1323-31.
120. Bhalerao DP, Rajpurohit Y, Vite CH, Giger U. Detection of a genetic mutation for myotonia congenita among Miniature Schnauzers and identification of a common carrier ancestor. Am J Vet Res. 2002 Oct;63(10):1443-7.
121. Lobetti RG. Myotonia congenita in a Jack Russell terrier. J S Afr Vet Assoc. 2009 Jun;80(2):106-7.
122. Rhodes TH, Vite CH, Giger U, Patterson DF, Fahlke C, George AL Jr. A missense mutation in canine C1C-1 causes recessive myotonia congenita in the dog. FEBS Lett. 1999 Jul 30;456(1):54-8.
123. Duncan ID, Griffiths IR, Nash AS. Myotonia in canine Cushing's disease. Vet Rec. 1977 Jan 8;100(2):30-1.
124. Greene CE, Lorenz MD, Munnell JF, Prasse KW, White NA, Bowen JM. Myopathy associated with hyperadrenocorticism in the dog. J Am Vet Med Assoc. 1979 Jun 15;174(12):1310-5.
125. Swinney GR, Foster SF, Church DB, Malik R. Myotonia associated with hyperadrenocorticism in two dogs. Aust Vet J. 1998 Nov;76(11):722-4.
126. Raja Rayan DL, Hanna MG. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol. 2010;23(5):466–76.
127. Statland JM, Barohn RJ. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. Continuum (Minneap Minn). 2013;19(6 Muscle Disease):1598–614.
128. Arimura Y, Nakamura T, Yoshimura M, Uehara A, Arimura K, Sakoda S, Takashima H. [The electrophysiologic diagnosis for muscle ion channelopathies]. Rinsho Shinkeigaku. 2012;52(11):1252-5.
129. Laing NG. Genetics of neuromuscular disorders. Crit Rev Clin Lab Sci. 2012 Mar-Apr;49(2):33-48.
130. Shelton GD, Liu LA, Guo LT, Smith GK, Christiansen JS, Thomas WB, Smith MO, Kline KL, March PA, Flegel T, Engvall E. Muscular dystrophy in female dogs. J Vet Intern Med. 2001 May-Jun;15(3):240-4.
131. Deitz K, Morrison JA, Kline K, Guo LT, Shelton GD. Sarcoglycan-deficient muscular dystrophy in a Boston Terrier. J Vet Intern Med. 2008 Mar-Apr;22(2):476-80.
132. Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, Hoffman E. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol. 2009 Jun;65(6):667-76.
133. Shimizu-Motohashi Y, Miyatake S, Komaki H, Takeda S, Aoki Y. Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials. Am J Transl Res. 2016 Jun 15;8(6):2471-89.
論文の公開元へ
